Gene set enrichment analysis (GSEA) also identified JAK-STAT3 signaling pathway as one of the interfered signaling pathways of lncRNA RP11-616M22.7, which was increased in the imatinib-resistant GIST samples (Shao et al., 2021). The gene discussed is STAT3; the disease is gastrointestinal stromal tumor.